ACRS Aclaris Therapeutics, Inc.
Healthcare$4.52-0.44%ClosedMarket Cap: $545.1M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$10.60
Target (Median)
$10.00
Target Range
$10.00 - $12.00
Upside from current price: 134.5%
Rating Distribution
1 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-05 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-04-29 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-19 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-28 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-20 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-06-25 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.66 | $5.8M | 8 |
| Sun Dec 31 | $-0.76 | $6.9M | 7 |
| Mon Dec 31 | $-0.82 | $28.4M | 2 |
| Tue Dec 31 | $-0.68 | $114.4M | 5 |